Podcast appearances and mentions of matt maurer

Joining host Chadi is a trio of esteemed guests – Drs. Andy Evans, Matt Maurer, and Susan Parsons – of the HoLISTIC (Hodgkin Lymphoma International Study for Individual Care) Consortium. In this riveting conversation, they delve into the consortium's pioneering efforts, bringing together an international team of experts to scrutinize the multifaceted dimensions of Hodgkin lymphoma, spanning prognosis, epidemiology, treatment, survivorship, and health outcomes across all age groups. The discussion circles around consensus protocols for treatment, referral pathways, and clinical trials, probing the necessity of transplants in the era of novel therapeutics and the creation of predictive models tailored to individual patient needs. Tune in to hear about the meticulous efforts invested in building the HoLISTIC portal, automating data migration, and navigating the challenges and progress in predictive modeling for treatment selection, response, and failure. This episode offers a captivating exploration of how collaboration, technology, and data analysis converge to shape the future of Hodgkin lymphoma care. Find out more about the HoLISTIC Consortium. https://www.hodgkinconsortium.com/ Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on YouTube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

Mercersburg's traditional Irving-Marshall Week is February 26-March 2, and to get the inside scoop on what to expect, join Declamation adviser Matt Maurer as he chats with the experts: Isabel Su '23 (Marshall president), Caroline Wilkinson '23 (Irving president), Amy Shaffer Post '02 (Irving adviser), and Bethany Galey '02 (Marshall adviser). Go Marshall! Go Irving!

ASCO: You're listening to a podcast from Cancer.Net. This cancer information website is produced by the American Society of Clinical Oncology, known as ASCO, the world's leading professional organization for doctors who care for people with cancer. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guests' statements on this podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Cancer research discussed in this podcast is ongoing, so data described here may change as research progresses. In this podcast, Cancer.Net Associate Editor Dr. Christopher Flowers covers new research in non-Hodgkin lymphoma presented at the 2022 American Society of Hematology Annual Meeting, held December 10-13 in New Orleans, Louisiana. Dr. Flowers is the Chair of the Department of Lymphoma/Myeloma at The University of Texas MD Anderson Cancer Center and was appointed Division Head ad interim of Cancer Medicine in August 2020. View Dr. Flowers' disclosures at Cancer.Net. Dr. Flowers: Hello and welcome to this Cancer.Net podcast. I'm Dr. Christopher Flowers, professor and chair of the Department of Lymphoma and Myeloma at the University of Texas MD Anderson Cancer Center. And it's my great pleasure to talk to you today about updates in lymphoma from this year's American Society of Hematology meeting in December of 2022. I have a number of disclosures related to my work as a consultant for companies in the development of therapies for lymphoma. I will not talk about agents specifically related to those companies, but 2 companies that overlap with some of the areas that I'll talk about in bispecific antibodies includes Genentech, Roche, and Genmab, as well as research support from those companies for research that is performed at MD Anderson. So this year's American Society of Hematology meeting had a number of highlights. I was very fortunate to be the introducer for one of those key highlights, and that was the abstract presented at this year's plenary session. This was actually the first abstract presented in the plenary session where I introduced the abstract and set the context, and Dr. Martin Dreyling from the German group described the TRIANGLE study. So the TRIANGLE study was a randomized controlled clinical trial, meaning that the trial was performed in a randomized fashion to be able to test 3 particular strategies for patients with mantle cell lymphoma. Mantle cell lymphoma, as many of you may know, is a relatively uncommon form of non-Hodgkin lymphoma. It's a kind of lymphoma that can be quite aggressive, and particularly for younger patients who are suitable for aggressive therapy, the role of autologous stem cell transplantation has been something that's been important for the first-line therapy for mantle cell lymphoma. This study evaluated the use of a standard regimen of giving R-CHOP chemotherapy alternating with R-DHAP chemotherapy. So a chemotherapy regimen that includes Ara-C as their component followed by autologous stem cell transplantation. And it compared using that same regimen to giving it with ibrutinib added to the R-CHOP portion of the chemotherapy, followed by ibrutinib maintenance after the stem cell transplant or another experimental arm that added ibrutinib to the R-CHOP portion of the chemotherapy and gave 2 years of ibrutinib maintenance without stem cell transplantation. I think, importantly, this arm compared to each of those 2 experimental arms versus the standard of care and showed graphically that both of the arms that contained ibrutinib, the BTK inhibitor, looked to have improved failure-free survival compared to the standard stem cell transplant arm. Formal statistical tests were performed to compare the arm that included transplant plus ibrutinib showing that that was superior to transplant alone. And it remains to be seen whether that arm is superior to the arm that used ibrutinib alone. But those 2 arms look fairly similar in terms of their outcomes, and also the toxicity associated with the transplant obviously was substantially more than performing the therapy without transplant. This suggested perhaps autologous stem cell transplantation can be removed from frontline therapy for patients with aggressive mantle cell lymphoma and provides provocative data that may help to change practice, both in Europe and in the United States, as well as the rest of the world. A few other abstracts that were presented at this year's ASH meeting presented provocative data about ways to be able to improve the ways that we predict outcomes for patients. Matt Maurer presented the results of the Follicular Lymphoma International Prognostic Index 24, or the FLIPI24, as a risk factor to try and predict patients who might have early progression of disease with follicular lymphoma. One of the things that we know is that when you look at patients with follicular lymphoma, those patients who have progression of their disease within 24 months of the start of chemoimmunotherapy are patients that have markedly worse outcomes. And Dr. Maurer and our colleagues led an international study showing that a new prognostic factor model that included age, hemoglobin, white blood cell count, normalized lactate dehydrogenase, and beta-2-microglobulin, so all laboratory values that are connected within routine clinical practice, along with age, were a better predictor of this early progression of disease. This may serve as a useful model moving forward to help patients and their providers to understand who are the patients who are at higher risk of having aggressive behaving follicular lymphoma, and eventually, we can make strategies that help to address that for those patients. A second provocative model for using integrated genomics helps to identify patients who also have early progression of disease, and those are for patients with diffuse large B-cell lymphoma. This was presented by Kirsten Wenzel from the Mayo group, where Anne Novak was the senior author for this publication. What they did was they integrated the genomics into the clinical prognostic factors and found that there was a particular RNA-seq profile that helped to identify those patients who had early progression of disease with diffuse large B-cell lymphoma. They compared this approach to other prognostic models and suggested that these approaches may be able to improve upon the prediction of outcomes and be incorporated into the ways that we predict treatment strategies for patients with diffuse large B-cell lymphoma in the future. While these are still early on in their development, I think this holds promise for the future management of patients. And then the other class of agents that I'll mention from this year's ASH meeting are the bispecific antibodies. There were several abstracts that addressed this, both in patients with relapsing, refractory, diffuse large B-cell lymphoma, and in patient populations with relapsing refractory follicular lymphoma. One of those highlighted came from Nancy Bartlett, who discussed the role of a specific bispecific antibody for patients with relapsed follicular lymphoma. And I think these agents hold broad promise. So I appreciate your time and attention and hope you enjoyed this podcast and look forward to talking to you in the future about new developments in lymphomas broadly. ASCO: Thank you, Dr. Flowers. You can find more research from recent scientific meetings at www.cancer.net. Cancer.Net Podcasts feature trusted, timely, and compassionate information for people with cancer, survivors, and their families and loved ones. Subscribe wherever you listen to podcasts for expert information and tips on coping with cancer, recaps of the latest research advances, and thoughtful discussions on cancer care. And check out other ASCO Podcasts to hear the latest interviews and insights from thought leaders, innovators, experts, and pioneers in oncology. Cancer.Net is supported by Conquer Cancer, the ASCO Foundation, which funds lifesaving research for every type of cancer, helping people with cancer everywhere. To help fund Cancer.Net and programs like it, donate at CONQUER.ORG/Donate.

Matt is a partner at the Toronto law firm Torkin Manes. He is co-chair of the Cannabis Law Group and chair of the Franchise Law Group. He is also an accomplished trial and appellate lawyer in the Litigation Group with over a decade of experience advocating on behalf of his business clients. Matt provides business and regulatory advice to a wide range of cannabis industry stakeholders, including licensed producers, producer applicants, owners of businesses that provide ancillary services to the cannabis industry, entrepreneurs with start-up aspirations and foreign businesses who are looking to enter the Canadian market or enter into partnerships with established Canadian cannabis businesses. Matt has developed considerable knowledge and expertise under the Cannabis Act and its predecessor legislation, including the Access to Cannabis for Medical Purposes Regulations. Matt prides himself on staying abreast of developing cannabis-related legislation at the federal, provincial and municipal levels across the entire country which allows him to service clients throughout Canada and internationally. He is frequently sought out by clients to assist in developing promotional strategies and navigating the complexities surrounding the promotional provisions of the Cannabis Act. Matt has acted for a number of American and international celebrities in advising them in their relationships with Canadian cannabis companies. Matt has helped clients obtain retail sales licenses across the entire country, including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and Newfoundland. Within his litigation practice, Matt acts for his business clients on a wide range of commercial disputes. He has had numerous successful attendances before the Court of Appeal for Ontario and regularly litigates his clients' cases in the Ontario Superior Court of Justice on trials, applications and motions. Matt has also successfully appeared before the Supreme Court of British Columbia and the Court of Queen's Bench of Alberta. Matt is a regular contributor to print and online media publications on issues pertaining to legal developments within the cannabis industry as well as corporate litigation. Matt is frequently sought out by Canadian media outlets to comment on issues pertaining to the cannabis industry and regularly speaks at industry conferences across the continent. Matt is also an editor of the Torkin Manes Cannabis Law Group blog. I hope you enjoy our conversation.For more insightful conversations related to cannabis law, listen to our other episodes at https://cannabislaw.ca/pages/russell-bennett-podcast If you're looking for a good text book on Canada's federal cannabis law and regulations with helpful related case law, read Canada's Cannabis Act.And if you need a cannabis lawyer, ask Russell for more information at https://cannabislaw.ca

It's that time of year again. If you have been with us from the start, then you know how awesome of a time this one will be. It's always an honor to bring back NBA Draft historian and friend of the podcast, Matthew Maurer! We get to catch up with Maurer, all of the projects he's currently working on, and of course pick his brain about this year's NBA draft.We are always grateful and forever fans of his work. Thank you Matthew Maurer!Be sure to check out Season 2 Episode 9 to learn more about Matthew Maurer and his incredible stories on how he got The Draft Review started.Also- Support and check out Thedraftreview.comThank you Matthew Maurer!You can find this episode on Apple, Spotify or any source for podcasts!Follow us on social media!Facebook - https://www.facebook.com/notin.myhouse.79Instagram- @Not_in_my_house_podcastTwitter - @NOTINMYHOUSEpc

Cannabis Daily is a cannabis news and interview program from Business of Cannabis. We highlight the companies, brands, people and trends driving the cannabis industry.Today's program has cannabis news on the MJBizDaily acquisition, MedMen and Ascend breaking up in New York, Wana getting the New York Times treatment and the Mayor of London pushing decriminalization.Tune in on YouTube everyday at 10 am Eastern: https://bofc.me/youtubeOur BofC Live segment a conversation with Matt Maurer of Torkin Manes LLP about the year ahead for Canadian cannabis law.

On this episode of BofC Live, we connect with Matt Maurer of Torkin Manes LLP. Torkin Manes it the Official Law Firm of Business of Cannabis. With the increased level of conversation and debate about the density of cannabis retail in Ontario – we wanted to connect with Maurer about the proposed legislation to provide municipalities with increased input in cannabis retail locations. Yesterday, Maurer penned this piece for Business of Cannabis: Is this the end of cannabis retail clustering in Ontario? to describe the proposed legislation as well as the history of private cannabis retail in the Province.BofC Live is the daily news and interview program of Business of Cannabis. Business of Cannabis highlights the companies, brands, people and trends driving the sector.

On this episode of BofC Live, we connect with Matt Maurer of Torkin Manes LLP. Torkin Manes it the Official Law Firm of Business of Cannabis. Maurer and his team at Torkin Manes co-presented an event on August 18th with Business of Cannabis titled: Canadian Cannabis: What's Next? – a full day, online event highlighting perspectives from throughout the Canadian cannabis supply chain.Maurer and Business of Cannabis Managing Director Jay Rosenthal penned a piece following the event titled: Three things to know about what's next in Canadian cannabis – and this conversation highlights that post.BofC Live is the daily news and interview program of Business of Cannabis. Business of Cannabis highlights the companies, brands, people and trends driving the sector.

On August 18, along with Torkin Manes LLP, Business of Cannabis presented the online event, “Canadian Cannabis: What's Next?”Matt Maurer, Co-Chair of Torkin Manes LLP's Cannabis Law Group and Krista Raymer, Co-Founder of Vetrina Group – a cannabis retail consultancy, joined the program to talk about the current state of mergers and acquisitions in the Canadian cannabis landscape. With the proliferation of cannabis retailers in Canada – and the fierce competition that has ensued – the landscape for cannabis retail is unsettled. Within this environment, M&A activity has picked up considerably, and Maurer and Raymer provided a deep dive into the landscape they are seeing on a day-to-day basis.

We get you updated with NFL Preseason scores.  MLB standings update.  Could Michael Jordan average 50 points per game?  Want to know more about off shore fishing?  Listen in as we have Special Guest:  Matt Maurer.  He tells his story and what you should consider if you want to fish in the ocean.

On this episode of BofC Live, we connect with Matt Maurer of Torkin Manes LLP. Torkin Manes it the Official Law Firm of Business of Cannabis and is the co-host, along with the firm Harris Bricken in Los Angeles, of Cross-Border Cannabis, an event this Friday, April 16 at Noon Eastern. Maurer joined BofC Live to talk about the upcoming event and what attendees can hope to learn from the program.Registration for the event is still open.BofC Live is the daily news and interview program of Business of Cannabis. Business of Cannabis highlights the companies, brands, people and trends driving the sector.

On this episode of BofC Live, we connect with Matt Maurer and Vlad Mihaescu of Torkin Manes LLP, the Official Law Firm of Business of Cannabis. Maurer and Mihaescu talked about the current state of affairs as it relates to cannabis beverages, including marketing regulations, potency equivalency levels and a possible path forward for regulatory changes.The conversation follows two beverage-related pieces published by the Torkin Manes LLP team on Business of Cannabis:To Co-Pack or Not to Co-Pack?Cannabis Beverages: Still the Next Big Thing or Not So Much?The conversation about cannabis beverages will continue on March 24 as part of our Cannabis Beverages. Register today.

We have an outstanding episode for all of you basketball nerds today. We have Matthew Maurer in the house! This episode is much different from our past ones and we mean that in the best way possible. Maurer is an NBA Draft Historian who created the online basketball draft history database, TheDraftReview.com. He was also the Senior Scout for NBADraft.net. He has contributed to CBS Sports, Eurobasket, Vice Sports, NBA.com and ESPN. The research he’s done for the Draft Review is truly incredible and we get to hear all about how he got it started, some incredible stories when researching former players, draft history facts, and MUCH more.We can’t thank Maurer enough for his time. We truly learned so much about the history of the NBA Draft and it was a joy hearing about some of the great lengths he went to research EVERY single player who was ever drafted. There is no episode quite like this one and it is hard to find others out there who truly love and appreciate both the history of the game and the players who paved the way like he does. We know you will agree after giving this one a listen.Thank you Matthew Maurer!Please support and checkout TheDraftReview.com

On this episode of BofC Live, we connect with Matt Maurer and James Leech of Torkin Manes LLP. Maurer and Leech posted a perspective: To Co-Pack or Not to Co-Pack? about co-packing in the Canadian cannabis sector. Read the perspective. The two joined BofC Live to talk about their perspective and how the cannabis industry should think about brand/co-packer relationships. BofC Live is the daily news and interview program of Business of Cannabis. Business of Cannabis highlights the companies, brands, people and trends driving the sector.

BofC Live is the daily news and interview program of Business of Cannabis. Business of Cannabis highlights the companies, brands, people and trends driving the sector.On this episode of BofC Live, we connect with Matt Maurer of Torkin Manes LLP, the Official Law Firm of Business of Cannabis. New COVID-related restrictions on operations of cannabis retailers went into effect Monday, November 23 – closing brick-and-mortar retailers to customers, but opening up curbside pick up and delivery. Maurer shared his perspective on what retailers can, and cannot, do in this new environment.As well, join Torkin Manes LLP and Business of Cannabis for Cannabis Retail 2021 | A Look Ahead on December 10, 2020. Sign up today.

Matt Maurer from The Draft Review joins Mike to talk some NBA Draft. Matt and Mike discuss Why he has Anthony Edwards going #1 to the T'Wolves, Why he's not a fan of LaMelo The Warriors plans at #2 Wiseman vs. Onkongwu Obi Toppin to the Cavs His sleeper picks Players he wouldn't draft Potential Trades Website - https://www.thedraftreview.com/ (https://www.thedraftreview.com/) Email - mmaurer@thedraftreview Twitter - https://twitter.com/thedraftreview (@thedraftreview) Support this podcast

On this BofC Live, Matt Maurer of the law firm Torkin Manes joins Business of Cannabis to talk about about the recent Torkin Manes and Business of Cannabis partnership announcement, cannabis retail in Ontario and how quickly things shift in the cannabis sector.Earlier in the month, Torkin Manes became the Official Law Firm of Business of Cannabis. Read more about the partnership and what it means for the Business of Cannabis audience.

On this episode - BofC Live features a conversation with Matt Maurer an attorney with a long history in the cannabis sector. Maurer is a partner and the Co-Chair of Torkin Manes LLP's Cannabis Law Group and the Chair of the Franchise Law Group.Learn more about Matt Maurer and Torkin Manes.

In this episode, we speak with Matt Maurer, Co-Chair of Torkin Manes LLP’s Cannabis Law Group and the Chair of their Franchise Law group. Matt tells us about the evolving landscape of the cannabis industry, with particular attention to retail, which has been catalyzed by COVID-19. You can find him on Twitter at @MattPMaurer and on LinkedIn by following this link: https://ca.linkedin.com/in/maurermatt.

Matt Maurer is a leading cannabis attorney in Canada and a partner at Torkin Manes in Toronto. In the wake of a lackluster year of cannabis retail in the Province of Ontario, an announcement was made on December 12, 2019 that a new approach was being executed in the Province. Maurer has digested the new approach and joined us the following day while at MJBizCon 2019 to talk to Jay Rosenthal of Business of Cannabis about the new approach and what it means for Ontario, for would-be retailers and for the Canadian cannabis sector overall.

Matt Maurer, chair of the Cannabis Law Group at Minden Gross, joins Angela Kokott on Calgary Today to discuss whether the Senate could delay the government's pot bill beyond the July deadline.

If anyone doubts the power of Motivation 3.0, they should listen to this episode. In the last couple of months, people from all over the world who have jobs, kids and lives have volunteered to help evolve Mixed Mental Arts and get the ideas that have been trapped in books for decades out into the world. Bryan and I have never met most of these people. Matt Maurer has worked on the website for no money. Nicole Page and Matt "Unicorn" Madonna have set up our t-shirt store and provided endless advice to improve the website. Cate Fogarty has been taking Hunter's wordy ramblings and distilling them into #knowledgebombs that in under 500 words sum up key mental tools to upgrade your cultural software. And even though Brian Otoya makes basically zero dollars he is personally funding ads to drive traffic our way. Chris Price and Jake Brady have stepped in to help teach Hunter how to not screw up the sound. Milk Toast reached out on Twitter and even offered to fly out to LA to help with that. There are a lot of people who are helping out and really it goes to prove something a Ukrainian grandmother once told Hunter: "Everywhere you go, people are nice. Governments are assholes." This has certainly been Hunter and Bryan's experience growing up. There are a lot of great people everywhere. Are they perfect? Nope. But they all have value and the challenge in unleashing the wisdom of crowds is getting all those people to work together. There's a great scene in the Michael Fassbender Steve Jobs movie where Woz asks Jobs what he does... Steve Wozniak: You can't write code... you're not an engineer... you're not a designer... you can't put a hammer to a nail. I built the circuit board. The graphical interface was stolen from Xerox Parc. Jef Raskin was the leader of the Mac team before you threw him off his own project! Someone else designed the box! So how come ten times in a day, I read Steve Jobs is a genius? What do you do? Steve Jobs: I play the orchestra, and you're a good musician. You sit right there and you're the best in your row.   And that, ladies and gentlemen, is the great challenge of the human family. It is not that the wisdom of crowds isn't there. It's that we need to get the orchestra playing together. For too long, we've been waiting for a conductor to come along. We want a leader who will tell us how to play together. And it's time to realize that that leader isn't forthcoming.   Recently, Isaiah Gooley (who I've also never met) wrote a post for MixedMentalArts.co that takes the Chinese proverb "Heaven is High and the Emperor is Far Away" and relates it to modern times. (http://mixedmentalarts.co/tian-gao-huangdi-yuan/) We have become so consumed with who is elected President or Prime Minister that we have forgotten that the wisdom of crowds comes from us. It comes from the orchestra. And if no one will emerge to play us then we must adopt the attitude of jazz. We play our notes and we listen to what other people are doing and we figure out how to build on what others are doing. The Mixed Mental Arts community is a place for anyone from anywhere in the world who wants to do it. If we get together and start playing really cool music, then more and more people will join us. They'll want to be a part of what we're doing.   If we build it, they will come.   However, the crucial word there is we. Bryan and Hunter have many, many failings. That is the great freedom they have. There's no need for them to worry about trying to seem like they have it all together. They don't. And probably nor do you. In fact, no one does. That's the nature of the world. There are 130 million books. There are so many terabytes of data. It's all far too much for an individual human mind. That's why we have to get together a crowd to solve all these problems. Heaven is High and the Emperor is Far Away. The challenge is in pulling together the orchestra in the greatest improv jazz in history. We're doing that. You should join.   And here is where it becomes important to realize the challenge we face: identity. You have been told stories about yourself. We tell stories about each other. And who we are and how we behave changes often within minutes. We get cut off in traffic and we get road rage. Someone opens the door for us and we feel all is right with the world. We get hangry and become snappy. We have a nap and want to give everyone a hug. And we all have our Fundamentalisms. We have things that trigger us and make us freak out. The challenge for all of us is to say sorry and kiss and make up.   So, let me say I'm sorry. I'm sorry if I've upset any of the people I've called Fundamentalists over the past few months. As I've said before, I'm sure you're lovely people and I could tell many wonderful stories about you. Every hero has a thousand faces. Why did I do this then? Because the world is in the grip of a lot of bad stories right now. And the way you beat the bad story is with better stories. And one story is a variation on the story of that Ukrainian grandmother. Most people are nice but there is a small number of people who are so hung up on their one thing that they are getting in the way of the orchestra playing together. And so, I called them out. Now, it's time to tell a different story. The story of us. The story of that big shared human experience. And that's why us Mixed Mental Artists want to make a series called #CultureMatters. We want to take everything we've learned in over 200 episodes and turn it into a series of fifteen videos that in two to three minutes will sum up everything we've learned. It will allow you to massively update your cultural software and drop #knowledgebombs all across the internet. It will make you an intellectual terrorist.   So fund intellectual terrorism by supporting us on Patreon. (https://www.patreon.com/mixedmentalarts) When we reach $10k, we can make these videos and you can go blow people's minds. And when we shatter those echo chambers, we will unleash the greatest idea orgy in human history.   Oh yeah! Let's get it on!

With the sounds of Bryan's offspring gently playing in the background, Bryan's thoughts turn to how to prepare the progeny he has sired from his loins for a world of constant technological disruption. Obviously, Bryan has already prepared them for the apocalypse. They're both proficient in using compound bow and dressing their own kills. They can also strip a firearm and set a bone. And thanks to Bryan's beautiful wife they have (like Alexander the Great, the Comanche, Mongol warriors and slightly foppish aristocrats) they have been rigorously trained in equestrian. These are basic skills that every Callen must know. But what if the apocalypse doesn't happen? What if society more or less continues as is and Bryan's children rather than stalking deer through the shattered wreckage of our civilization and leading conquering hordes on horseback instead find themselves getting jobs. What jobs can they get and how should he prepare them for that? And that, ladies and gentlemen, turns out to be a question we should all be asking. We are in the middle of a #Jobocalypse and it's only going to get worse. While Donald Trump told a great story about jobs going overseas and the coming back, it's not a very good reflection of what's actually been happening. Instead, the shift of jobs overseas was made possible by improved technology. You can't have a call center answering calls half a world away if you don't have good telecommunications technology. You can't manufacture goods in China for sale in America unless shipping technology is so good, cheap and efficient as to make it economically viable. The Donald can bring some jobs back but the greater force at work here is that much of routine work is being and will continue to be automated out of existence. If your job rests on doing routine tasks, then it can be done by a robot or software. Automated cars and trucks, accounting software, McDonalds self-service kiosks and computer programs that trade stocks and write increasingly complex legal contracts are all just some of the ways in which life-long careers can be either disrupted out of existence or change so massively as to be unrecognizable. The defining feature of the future is the need to constantly adapt and that is not something that the world has been prepared for. To reform an educational system, you first need to reform the understanding of the voters. That's the core challenge. Using the internet to empower people to take charge of their own educations. And that is what Mixed Mental Arts and The Straight-A Conspiracy are all about. As WhatUpO recently wrote on the Mixed Mental Arts subreddit: "I found MMA through the JRE and was hooked from the first episode I listened to (the Jordan Peterson episode I believe). The discussions had on the podcast about culture and learning are captivating not only because they are full of interesting info but because of how genuinely the ideas are presented. Today's entertainment/news realms only seem to deal in absolutes. MMA's "you don't have to believe us - look for yourselves" approach is a breath of fresh air to say the least. I've listened to all of the past podcasts and I'm just now discovering these extra resources that have been set up (the blog, this sub and the website) and I've begun diving into the books in the reading list so this won't be the last you hear from me!" Bryan Callen and Hunter Maats do not have all the answers. We do, however, have relentless faith in the wisdom of crowds. There's nothing that a random group of humans can't figure out if they all bring their minds to bear on the problem. And, now, it seems that is happening. People like Martin Totland in Norway and Cate Fogarty in LA are contributing blogposts. Sandy Bagga in Canada has set up a subreddit and Chris Reid in New Zealand has populated it with threads. Matt Maurer and Matt Madonna have built a way better website than the TERRIBLE one Hunter made. And all of this has been done by people (who like Bryan and Hunter) are not in it for the money. And Nicole Page Lee has connected Hunter with the similarly-minded Argument Ninja and helped design t-shirts and pressure Hunter to make them. Individually, none of us can solve the world's problems. Together, we can draw together people from all over the world who can do a better and better job of figuring it out. The key to doing that is the same as the key to thriving and surviving in the wake of the #Jobocalypse. Every day, we wake up and we put the white belt back on. We approach the world with a Beginner's Mind and make whatever progress we can make and learn whatever we can trusting that if we keep evolving then it will all add up to measurable results and lives changed for the better. We've made some crude knowledge bombs with these podcast episodes and blogposts. Now, it's time to make better knowledge bombs that can empower the Mixed Mental Arts community to go out there and be #IntellectualTerrorists. We want to make videos so short, so tight, so powerful and so thought-provoking that you can drop them on your Facebook feed, twitter feed or all around the internet and blow people's minds. We want to make a simple set of videos called #CultureMatters. To do that, we need to raise money on Patreon. (https://www.patreon.com/mixedmentalarts.) We work for free but equipment costs money and so do quality editors. For $10,000, we can produce those ten #CultureMatters videos that can set the internet on fire. We can make millions of people take the red pill. This is now the work of Mixed Mental Arts to keep refining better and better tools to diffuse innovations. You can contribute money as Bryan has by paying for renting the studio and Hunter has by paying for the first version of the blog. You can contribute skills like Matt Maurer and Matt Madonna. You can make connections like Nicole Lee Page. You can write blogposts like Martin Totland. You can challenge Hunter to look at blindspots you think he's avoiding like @mazz77a and Ro'ee Orland. Or you can set up your own dojo like Leland Chandler IV. Yes, you can set up your own dojo. In fact, we hope you do. Mixed Mental Arts doesn't belong to us. It's an approach to thinking just like Mixed Martial Arts is an approach to fighting. The goal is to have thinking styles compete and test each other. Bryan Callen and Hunter Maats want competition. We want to be forced to raise our game. Do it. Show us how it's done. Beat us at our own game. Mixed Mental Arts will evolve in the exact same way as Mixed Martial Arts. The best is yet to come. We're just getting started. That's what the Buddhist monks knew that we're only just rediscovering. It's all about putting the white belt back on every single day.

When Michael Phelps bought a ring for his girlfriend at a small retail shop then shared it online, thousands of his more than one million followers flooded the website of this small jewelry shop. That massive increase in traffic could’ve caused the site to crash. But as a customer of WebScale, the site was ale to adapt. Businesses dream of having their website flooded with orders. But for some, when it happens, it’s a nightmare! Everything comes to a stop in the surge of traffic. Why? Because they don’t have the infrastructure to support the number of people creating transactions on their site. Webscale CEO Sonal Puri talks about how her company is helping businesses of all sizes leverage the cloud to avoid crashes. In our “HealthTech” series, Stroll Co-founder and COO Matt Maurer talks about how he’s helping doctors guide their patients on the best, most cost-effective options for medical tests. If you have to get an MRI or an ultrasound, prices can vary by as much as $10,000 within a few miles. His technology provides that information to your doctor before you even leave their office. Plus, UpRamp Managing Director Scott Brown shares four startups that have the potential for disrupting the Cable industry.

  Matt will discuss the rapidly changing environment in mortgage servicing rights (MSR) trading.  Who are the new players, pricing expectations, sellers and enhanced analytics? Matt Maurer is Managing Director at MountainView Servicing Group and MountainView Capital Group.  Matt Maurer is responsible for providing residential mortgage servicing rights and whole loan sales advice, portfolio valuation and risk management.